Warhound Launches $200M Program to Clone Elite Military Dogs

The US military is moving to expand its canine workforce through a new private venture.

Warhound, a startup co-founded by Ben Lamm of Colossal Biosciences and Palmer Luckey of Anduril, has raised $200 million to genetically engineer dogs for defense applications.

The company has already begun modifying cell samples from top-performing service animals. These donors include Belgian Malinois, Labrador Retrievers, and German Shepherds currently serving in military, police, and first responder roles across the United States.

Scientists at Colossal Biosciences will edit the genes of these samples before cloning the animals. The initial phase of the research targets the reduction of breed-specific health issues, such as hip dysplasia and certain cancers. Lamm told TechCrunch that future genetic modifications could enhance speed, agility, and olfactory capabilities.

Anduril’s involvement is limited to hardware and software rather than biological engineering. The company will design protective gear for the dogs, including goggles, vests, and body armor. The partnership does not currently include plans for cyborg enhancements.

David Spirk, formerly of Palantir, serves as the company’s CEO. While Luckey is a partner, he and Anduril do not hold equity in the venture. Colossal Biosciences retains a stake, and Lamm occupies a seat on the board.

Warhound expects the first generation of these engineered dogs to be born in early 2027. The animals will be trained for standard working duties, including bomb detection and search-and-rescue operations.